Category Archives: Transfeminine

Special considerations for breast augmentation in trans women

Posted on October 31, 2020 by Zinnia Jones

Note: This post contains illustrations of breast anatomy. Among trans women and transfeminine people, breast augmentation surgery is both frequently sought after and frequently received compared to the population of cis women. According to the 2015 U.S. Trans Survey, 8% … Continue reading →

Posted in Outcomes of transition, Surgery, Transfeminine | Tagged , | 1 Comment

Update on cases of lymphoma linked to textured breast implants in transgender women (BIA-ALCL)

Posted on September 30, 2020 by Zinnia Jones

I’ve previously covered emerging findings on breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL), a type of non-Hodgkin’s lymphoma caused by the textured surfaces of some implants used in breast augmentation surgeries. Textured surfaces have been used in some breast implants to … Continue reading →

Posted in Health care, Oncology, Surgery, Transfeminine | Tagged , | Leave a comment

Lower doses of cyproterone acetate may be similarly effective for blocking testosterone, with a lower risk of adverse effects

Posted on September 1, 2020 by Zinnia Jones

Previously: Cyproterone acetate and meningioma risk in trans women (March 2018) Update on case reports: Cyproterone acetate and meningioma in trans women (November 2018) Disclaimer: I am not a medical professional and this is not medical advice. Cyproterone acetate (CPA) … Continue reading →

Posted in Endocrinology, Oncology, Transfeminine, Transgender medicine | Tagged , , , | 1 Comment